We’ve created a novel inhaled drug delivery platform to effectively deliver a broad range of pharmaceuticals. Our disruptive drug delivery technology is more than a medical device; it is a technology platform with multiple applications that have the potential to affect the lives of billions.

Our proprietary inhalation-based technology addresses many of the limitations of traditional pharmaceutical drug delivery systems to improve patient outcomes. We provide a platform that optimizes and tracks dosing, increases efficacy and improves patient compliance while delivering on the human factors patients desire.

We are currently pursuing FDA approval to help curb the world’s largest cause of preventable death and disease, smoking. More than eight million die from tobacco use every year and our goal is to help the world’s one billion smokers to finally quit smoking.

We aim to redefine the standard of effective, inhaled drug delivery by partnering with the world’s leading healthcare companies. We have the potential to both improve efficacy of existing drug therapies and to help deliver a variety of new inhaled therapies to patients.